BIORCHESTRA Co., Ltd. vs Sudo Biosciences
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift for neurodegenerative disease
16 employees · est. 2016 · Cambridge, United States
Sudo Biosciences
Developing precision TYK2 therapeutics
27 employees · est. 2020 · Carmel, United States
BIORCHESTRA Co., Ltd. is the older company (2016 vs 2020).
Side-by-Side Comparison
| Metric | BIORCHESTRA Co., Ltd. | Sudo Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2020 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Carmel, United States |
| Employees | ||
| Employees | 16 | 27 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Series B |
| Total Funding | ||
| Total Funding | $71.50B | $67.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 2 |
| Services | ||
| Services | Development of RNA medicines, Delivery systems for CNS diseases, Target discovery and drug development | Development of first and best-in-class medicines, Therapies for neurological and immunological diseases, Drug design and optimization, Clinical trial management |
| Target Customers | ||
| Target Customers | Patients with neurodegenerative diseases, Individuals with rare CNS disorders, Healthcare providers and medical researchers | Patients with serious neurological conditions, Patients with immune-mediated inflammatory conditions, Healthcare providers and institutions |
| Taxonomy | ||
| Taxonomy | RNA-based TherapeuticsNeurodegenerative DiseasesNeuroinflammatory DiseasesClinical DevelopmentR&D CollaborationBiotech Innovation +9 | BiopharmaceuticalPrecision TherapeuticsTYK2 Pseudokinase DomainCytokine SignalingImmune-Mediated Inflammatory ConditionsMultiple Sclerosis +9 |
| Website | ||
| Website | biorchestra.com | sudobio.com |
About BIORCHESTRA Co., Ltd.
BIORCHESTRA Co., Ltd. is a pioneering biotech company established in 2016, aiming to significantly advance therapeutics through innovative RNA-based solutions. The company is at the forefront of shifting treatment paradigms in the realm of neurodegenerative diseases, moving from symptomatic relief t...
About Sudo Biosciences
Sudo Biosciences, founded in 2020 and headquartered in the United States, is a burgeoning force in the biopharmaceutical sector. With a focused mission encapsulated by its slogan, "Developing precision TYK2 therapeutics," the company is committed to delivering innovative, best-in-class medicines aim...
Also comparing in this category
Comparing more than these two?
Get BIORCHESTRA Co., Ltd., Sudo Biosciences and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does BIORCHESTRA Co., Ltd. compare?
A PDF of BIORCHESTRA Co., Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare BIORCHESTRA Co., Ltd. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at BIORCHESTRA Co., Ltd. on 15 Jun 2026, and Sudo Biosciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
